BGI didn’t infringe one Illumina patent, fails to invalidate another

The US District Court for the Northern District of California has denied an attempt by Chinese company BGI Genomics to invalidate an Illumina DNA sequencing patent in a summary judgment, leaving the dispute over infringement of another Illumina patent to be decided at trial.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

3 August 2026 The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims.

MedTech

European court strikes down hearing aid sensor patent

30 July 2026 A dispute over optical sensor technology in miniature hearing devices ended with the EPO revoking a patent, finding the invention obvious despite ruling it was new over the closest prior art.

MedTech

Boston Scientific overturns $42m patent verdict on appeal

28 July 2026 Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.

More features

K&L Gates expands European practice with Munich team hire

Exclusive: Winston Taylor’s UK head of IP on pitching $1.75bn firm’s ‘humble, but lethal’ practice

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

Arnold & Porter adds firepower to ITC practice with new partner hire

USPTO director steps into Sun Pharma’s PTAB-ITC clash

USPTO appoints new acting commissioner for patents

European court strikes down hearing aid sensor patent

Where Big Pharma is betting big in the M&A boom

BGI didn’t infringe one Illumina patent, fails to invalidate another

More on this story

Editor's picks

Editor's picks

More features